Opaleye Management »

Glaukos shares owned by Opaleye Management

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by Opaleye Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $809k 8.6k 94.29

More positions owned by Opaleye Management

Ocular Therapeutix (OCUL)
Harrow Health (HROW)
Tg Therapeutics (TGTX)
Keros Therapeutics (KROS)
Rhythm Pharmaceuticals (RYTM)
Catalyst Pharmaceutical Partners (CPRX)
Arvinas Ord (ARVN)
Iovance Biotherapeutics (IOVA)
Jasper Therapeutics Com New (JSPR)
Edgewise Therapeutics (EWTX)
Applied Therapeutics (APLT)
4d Molecular Therapeutics In (FDMT)
Codexis (CDXS)
Protara Therapeutics Com Stk (TARA)
Acelyrin (SLRN)

View all positions for Opaleye Management

Top funds holding Glaukos

BlackRock
FMR
Vanguard Group
Henderson Group
Lord, Abbett & Co
Ameriprise Financial
Millennium Management
Wellington Management Company
Fred Alger Management
Artisan Partners Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
PRIMECAP Management Company
Morgan Stanley
Riverbrige Partners

View all funds holding Glaukos